Initial trial on NHI reimbursement price negotiation failed.

Published: 2003-11-13 07:00:00

Updated: 2003-11-13 07:00:00

The NHI reimbursement price negotiation between the medical and pharmacy communities and the NHI corporation in the morning on Nov. 11 went failure due to too distant positions, signaling a difficult future.

The NHI financial management committee suggested 51.5 won per a point (about 7% price ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK